Manufacturing Pace Is Key For COVID-19 Vaccine Candidates Hoping To Jump To ‘Warp Speed’

 
• By Sarah Karlin-Smith

Ease of manufacturing scale up may determine which candidates advance furthest in the US government's partnership with industry to speed COVID-19 vaccines to patients. Senior government officials also discussed approval standards, how a vaccine would be distributed, and how much the government and Americans could pay in a 16 June press call.

Syringe vaccine and vaccine production. Mass-produced syringes with the vaccine contained in it. The new syringes are labelled with the word “vaccine” and the needles have a grey safety lid on them.
Ability to quickly scale up vaccine manufacturing may be a key factor in Operation Warp Speed success • Source: Shutterstock

More from Manufacturing

More from Compliance